Moxilen (Amoxicillin)

Amoxicillin interferes with bacterial cell wall synthesis by binding to penicillin‑binding proteins. This blocks the cross‑linking of peptidoglycan layers, weakening the wall and causing bacterial lysis. The action is bactericidal against a broad range of Gram‑positive and some Gram‑negative bacteria.

The dosage of Moxilen is determined by the prescribing clinician based on the type and severity of infection, patient age, weight, and renal function. Only a qualified health professional can set the appropriate dose and administration schedule.

Amoxicillin is classified as Pregnancy Category B, indicating no evidence of risk in animal studies and limited human data. It may be used during pregnancy when the benefit outweighs potential risk. Small amounts are excreted in breast milk; breastfeeding is generally considered compatible, but a physician should evaluate each case.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and any required import documentation.

Moxilen (amoxicillin) offers a broader spectrum against Gram‑positive organisms compared with penicillin G and is more stable in acidic environments than ampicillin. It is often preferred for oral and parenteral therapy due to its favorable pharmacokinetics, but clinicians may choose alternatives like ceftriaxone for resistant strains or specific infection sites.

Moxilen should be stored at ambient temperature, below 25 °C, in its original container. Protect the product from moisture, direct sunlight, and extreme temperatures to maintain potency. Do not freeze the solution.

Moxilen is supplied as a sterile injectable solution for intramuscular or intravenous administration. The route, rate, and duration of infusion are determined by the prescriber, taking into account the infection type, patient condition, and any renal adjustments.

Serious risks include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, Clostridioides difficile‑associated colitis, and rare hematologic events like hemolytic anemia. Patients should be monitored for signs of rash, difficulty breathing, persistent diarrhea, or unexplained bruising, and medical attention should be sought immediately if they occur.

Moxilen is contraindicated in individuals with a documented hypersensitivity to amoxicillin, other penicillins, or any component of the formulation. Patients with a history of severe allergic reactions to beta‑lactam antibiotics should avoid this product and discuss alternative therapies with their healthcare provider.